{
  "state": "district-of-columbia",
  "path": "title-31/chapter-38",
  "sections": [
    {
      "id": "section-31-3801",
      "number": "31-3801",
      "heading": "Payable benefits.",
      "text": "All individual and group health insurance policies providing coverage on an expense-incurred basis and individual and group service-or indemnity-type contracts issued by a nonprofit health service plan shall provide that health insurance benefits shall be payable with respect to a newly born child of the insured or subscriber from the moment of birth.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 2, 26 DCR 1116",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3801.html"
    },
    {
      "id": "section-31-3802",
      "number": "31-3802",
      "heading": "Extent of coverage.",
      "text": "Repealed.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 3, 26 DCR 1116; May 21, 1992, D.C. Law 9-99, § 2(a), 39 DCR 2142; Apr. 13, 2005, D.C. Law 15-353, § 351, 52 DCR 2331",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3802.html"
    },
    {
      "id": "section-31-3802.01",
      "number": "31-3802.01",
      "heading": "Inpatient postpartum treatment; at-home post-delivery care.",
      "text": "(a) Except as provided in subsection (b) of this section, all individual and group health policies providing maternity and newborn care coverage on an expense-incurred basis and individual and group service or indemnity type contracts issued by a nonprofit health service plan, including policies issued by Group Hospitalization and Medical Services, Inc., shall provide coverage for inpatient postpartum treatment in accordance with the medical criteria outlined in the most current version of or an official update to the Guidelines for Perinatal Care (“Guidelines”) prepared by the American Academy of Pediatrics and the American College of Obstetricians or the Standards for Obstetric-Gynecologic Services (“Standards”) prepared by the American College of Obstetricians and Gynecologists, and such coverage must include an in-hospital stay of a minimum of 48 hours after a vaginal delivery, and 96 hours after a Caesarian delivery.\n\n(b) A private review agent or health maintenance organization may authorize a shorter length of stay if the physician, in consultation with the mother, determines that the newborn and mother meet the criteria for medical stability in accordance with the Guidelines or Standards.\n\n(c) In all cases of early discharge pursuant to subsection (b) of this section, the insurer shall provide coverage for post-delivery care within the minimum time periods established in subsection (a) of this section, to be delivered in the patient’s home, or, in a provider’s office, as determined by the physician in consultation with the mother. The at-home post-delivery care shall be provided by a registered professional nurse, physician, nurse practitioner, certified midwife, certified nurse-midwife, or physician assistant experienced in maternal and child health, and shall include:\n\n(1) Parental education;\n\n(2) Assistance and training in breast or bottle feeding; and\n\n(3) Performance of any medically necessary and clinically appropriate tests, including the collection of an adequate sample for hereditary and metabolic newborn screening.\n\n(d) Upon notification of the pregnancy of the insured, the insurer shall:\n\n(1) Encourage and assist the insured, prior to the delivery date, to select and contact a primary care provider for the expected newborn prior to delivery; and,\n\n(2) Provide the insured prior to the delivery date with information on postpartum home visits for the mother and child that includes the names of providers that are available for postpartum home visits.\n\n(e) No insurer may deselect, terminate the services of, require additional documentation from, require additional utilization review, reduce payments, or otherwise provide financial disincentives to any attending provider who orders care consistent with this chapter.\n\n(f) Every insurer shall provide notice to policyholders regarding the coverage required under this chapter. The notice shall be in writing and shall be transmitted at the earliest of either the next mailing to the policyholder, the yearly summary of benefits sent to the policyholder, or January 1 of the year following April 9, 1997.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 3a; as added Apr. 9, 1997, D.C. Law 11-241, § 3, 44 DCR 1125",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3802.01.html"
    },
    {
      "id": "section-31-3803",
      "number": "31-3803",
      "heading": "Notification of birth and payment of premiums or fees.",
      "text": "If payment of a specific premium or subscription fee is required to provide coverage for a child, the policy or contract may require that notification of birth of a newly born child and payment of the required premium or fees must be furnished to the insurer or nonprofit service or indemnity corporation within 31 days after the date of birth in order to have the coverage continue beyond such 31-day period.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 4, 26 DCR 1116",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3803.html"
    },
    {
      "id": "section-31-3804",
      "number": "31-3804",
      "heading": "Applicability of chapter.",
      "text": "The requirements of this chapter shall apply:\n\n(1) To all insurance policies and subscriber contracts delivered or issued for delivery in the District more than 120 days after October 20, 1979.\n\n(2) To all such insurance policies and subscriber contracts renewed, amended or reissued after 120 days following October 20, 1979;\n\n(3) To only children born more than 120 days after October 20, 1979;\n\n(4) To all individual subscriber contracts and group certificates issued or delivered in the District of Columbia by Group Hospitalization and Medical Services, Inc.;\n\n(5) To all for-profit as well as nonprofit indemnity type health insurers issuing or delivering individual indemnity type accident and sickness health insurance policies and group certificates in the District of Columbia; and\n\n(6) To health insurance certificates, except those described in § 31-3802(2) [repealed], that are delivered within the District of Columbia from group health insurance policies which are sold outside of the District of Columbia.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 5, 26 DCR 1116; May 21, 1992, D.C. Law 9-99, § 2(b), 39 DCR 2142",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3804.html"
    },
    {
      "id": "section-31-3805",
      "number": "31-3805",
      "heading": "Exclusions.",
      "text": "Specifically excluded from the coverage requirements of this chapter are Medicare Supplement insurance policies, accident only policies, dread disease policies, student accident policies, nursing home policies, and home health care policies.",
      "history": "Oct. 20, 1979, D.C. Law 3-33, § 6; as added May 21, 1992, D.C. Law 9-99,§ 2(c), 39 DCR 2142",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3805.html"
    },
    {
      "id": "section-31-3821",
      "number": "31-3821",
      "heading": "Definitions.",
      "text": "For the purposes of this chapter, the term:\n\n(1) “Aggregate attachment point” means the total amount of health claims incurred by a small employer in a policy year for all covered employees and their dependents, and covered by a stop-loss insurance policy, above which the stop-loss insurer incurs a liability for payment under aggregate stop-loss coverage.\n\n(2) “Attachment point” means the claims amount incurred by an insured group beyond which the insurer incurs a liability for payment.\n\n(3) “Commissioner” means the Commissioner of the Department of Insurance, Securities and Banking.\n\n(4) “Expected claims” means the total amount of claims that, in the absence of medical stop-loss insurance, are projected to be incurred by the insured using reasonable and accepted actuarial principles in a policy year.\n\n(5) “Individual attachment point” means the amount of health claims incurred by a small employer in a policy year for an individual employee or dependent of an employee, and covered by a stop-loss insurance policy, above which the stop-loss insurer incurs a liability for payment, under individual stop-loss coverage.\n\n(6) “Stop-loss insurance” means coverage that insures an employer or an employer-sponsored health plan against the risk that:\n\n(A) One claim will exceed a specific dollar amount; or\n\n(B) The entire loss of a self-insurance plan will exceed a specific dollar amount.",
      "history": "May 2, 2015, D.C. Law 20-265, § 201, 62 DCR 1529",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3821.html"
    },
    {
      "id": "section-31-3822",
      "number": "31-3822",
      "heading": "Stop-loss policy.",
      "text": "(a) An insurer shall not issue or deliver to a small employer, as defined in §31-3301.01(42), a stop-loss insurance policy unless the employer has a fully-insured employee health benefit plan.\n\n(b) Stop-loss insurance is subject to the following:\n\n(1) The policy must be issued to and insure the employer, the trustee, or other sponsor of the plan, or the plan itself, but not the employees, members, or participants;\n\n(2) Payment by the insurer must be made to the employer, trustee, or other sponsor of the plan, or to the plan itself, but not to the employees, members, participants, or health care providers; and\n\n(3) Stop-loss insurance policies issued or renewed after May 2, 2015, shall not contain any of the following provisions:\n\n(A) An individual attachment point for a policy year that is less than $40,000.\n\n(B) An aggregate attachment point for a policy year that is less than the greater of one of the following:\n\n(i) Five thousand dollars times the total number of group members;\n\n(ii) One hundred twenty percent of expected claims; or\n\n(iii) Forty thousand dollars.\n\n(1) A stop-loss insurer shall not exclude any employee or dependent on the basis of an actual or expected health status-related factor.\n\n(2) Health status-related factors include any of the following: health status; medical condition, including both physical and mental illnesses; claims experience; medical history; receipt of health care; genetic information; disability; evidence of insurability, including conditions arising out of acts of domestic violence of the employee or dependent; or any other health status-related factor as determined by the Commissioner.\n\n(d) A stop-loss insurer shall not cancel or not renew a stop-loss insurance policy except if:\n\n(1) The employer has failed to make the required premium payments;\n\n(2) The employer demonstrates fraud or an intentional misrepresentation of material fact under the terms of the stop-loss insurance policy;\n\n(3) The stop-loss insurer has been determined by the Commissioner to be financially impaired; or\n\n(4) The stop-loss insurer ceases to write, issue, or administer new stop-loss insurance policies in the District; provided, that the following conditions are satisfied:\n\n(A) The insurer provides notice to the Commissioner and employer of its intent to cease writing, issuing, or administering new or existing stop-loss insurance policies in the District at least 180 days before the date the insurer seeks to discontinue the coverage; and\n\n(B) The insurer provides the employer at least 180 days advance written notice of its intent to cancel stop-loss insurance coverage beginning from the date of discontinuation provided to the Commissioner pursuant to subparagraph (A) of this paragraph.\n\n(e) If an insurer elects to cancel or not renew an employer’s stop-loss insurance pursuant to subsection (d)(1) of this section, the insurer shall:\n\n(1) Provide the employer notice no less than 30 days before the date of cancellation or expiration of the policy period;\n\n(2) Accept any premium payment by the employer that would satisfy any outstanding amounts owed to the insurer and cure the deficiency giving rise to the cancellation or non-renewal; and\n\n(3) Continue the policy in full force until the date of cancellation or expiration provided in the notice.\n\n(f) Nothing in this section shall be construed to extinguish, limit, or otherwise impair any existing right in law or equity arising under a stop-loss insurance policy.\n\n(g) On April 1, 2015, and on April 1 annually thereafter, a stop-loss insurer shall report to the Commissioner the number of small employer stop-loss policies it had issued and in effect as of December 31 of the previous year. The information in the report shall include new policies issued and policies reissued or renewed in the previous year for groups that have 1 to 50 employees and 51 to 100 employees.\n\n(h) The provisions of this section shall apply to stop-loss insurance policies issued or renewed after May 2, 2015.\n\n(i) The Commissioner, pursuant to subchapter I of Chapter 5 of Title 2 [§ 2-501 et seq.], may issue rules to implement the requirements of this section, including rules providing for:\n\n(1) Additional standards for employee benefit stop-loss insurance policies; and\n\n(2) Required disclosures to policyholders by an insurance carrier providing employee benefit stop-loss insurance.",
      "history": "May 2, 2015, D.C. Law 20-265, § 202, 62 DCR 1529",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3822.html"
    },
    {
      "id": "section-31-3831",
      "number": "31-3831",
      "heading": "Definitions.",
      "text": "For the purposes of this chapter, the term:\n\n(1) “Commissioner” means Commissioner of the Department of Insurance and Securities Regulation.\n\n(2) “District” means the District of Columbia.\n\n(3) “Group health plan” means an employee welfare plan (as defined in section 3(1) of the Employee Retirement Income Security Act of 1974, approved September 2, 1974 (88 Stat. 829; 29 U.S.C. § 1002(1)), to the extent that the plan provides medical care and includes items and services paid for as medical care to employees or their dependents (as defined under the terms of the plan) directly or through insurance, reimbursement, or otherwise.\n\n(4) “Health insurance coverage” means benefits consisting of medical care (provided directly, through insurance or reimbursement, or otherwise and includes items and services paid for as medical care) under any hospital or medical service policy or certificate, hospital, or medical service plan contract, or health maintenance organization contract offered by a health insurer.\n\n(5) “Health insurer” means any person that provides one or more health benefit plans or insurance in the District, including an insurer, a hospital and medical services corporation, a fraternal benefit society, a health maintenance organization, a multiple employer welfare arrangement, or any other person providing a plan of health insurance subject to the authority of the Commissioner.\n\n(6) “Health benefit plan” means any accident and health insurance policy or certificate, hospital and medical services corporation contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement, or plan provided by another benefit arrangement. The term “health benefit plan” does not mean accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplement or long-term care insurance; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; coverage issued as a supplement to liability insurance; insurance arising out of a workers’ compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.\n\n(7) “Individual health plan” means a plan offering health insurance coverage offered to individuals other than in connection with a group health plan.\n\n(8) “Mastectomy” means the surgical removal of all or substantially all of a breast as a result of breast cancer.\n\n(9) \"Vasectomy\" means a medical procedure to cut or seal the vas deferens tubes that carry a person's sperm to permanently prevent pregnancy.\n\n(10) \"Voluntary sterilization\" means a vasectomy, tubal ligation, or any medical procedure to permanently prevent pregnancy.\n\n(11) \"Voluntary sterilization procedures and services\" means consultations, procedures, or follow-up appointments related to a voluntary sterilization, including up to 2 voluntary sterilization reversals.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 2, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3831.html"
    },
    {
      "id": "section-31-3832",
      "number": "31-3832",
      "heading": "Coverage for reconstructive surgery following mastectomies.",
      "text": "(a) An individual or group health plan which is a health benefit plan, and a health insurer providing health insurance coverage, that provides medical and surgical benefits with respect to a mastectomy shall, in a manner determined in consultation with the attending physician and the patient, provide the following coverage in the case of a participant or beneficiary who is receiving benefits in connection with a mastectomy and who elects breast reconstruction in connection with such mastectomy:\n\n(1) All stages of reconstruction of the breast on which the mastectomy has been performed;\n\n(2) Surgery and reconstruction of the other breast to produce a symmetrical appearance; and\n\n(3) Prostheses and physical complications at all stages of mastectomy, including lymphedemas.\n\n(b) Coverage for the procedures in subsection (a) of this section may be subject to annual deductibles and coinsurance provisions as may be considered appropriate and as are consistent with those established for other benefits under the health benefit plan or coverage.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 3, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3832.html"
    },
    {
      "id": "section-31-3833",
      "number": "31-3833",
      "heading": "Notice.",
      "text": "(a) Written notice of the availability of coverage, as set forth in § 31-3832, shall be delivered to the participant and beneficiary under the health plan upon enrollment and annually thereafter. Notice of the benefits shall be prominently positioned in any literature or correspondence made available or distributed by the health benefit plan or health insurer and shall be transmitted to the participant or beneficiary upon the earlier of:\n\n(1) Any yearly informational packet sent to the participant or beneficiary, as part of the packet;\n\n(2) In the next mailing made by the health benefit plan or health insurer to the participant or beneficiary; or\n\n(3) Not later than 60 days after April 3, 2001.\n\n(b) An individual or group health plan which is a health benefit plan, and a health insurer that has already provided notice in order to comply with the Women’s Health and Cancer Rights Act of 1998, approved October 21, 1998 (112 Stat. 2681; 29 U.S.C. § 1185b, 42 U.S.C. § 300gg-6, and 42 U.S.C. § 300gg-52), need not provide additional notice under this chapter; provided, that it files with the Commissioner a written statement, with a copy of the notice attached, certifying that it is in compliance.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 4, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3833.html"
    },
    {
      "id": "section-31-3834",
      "number": "31-3834",
      "heading": "Hormone replacement therapy coverage.",
      "text": "An individual or group health plan, and a health insurer offering health care coverage that provides coverage for prescription drugs, shall provide benefits which cover any hormone replacement therapy that is prescribed or ordered for treating symptoms and conditions of menopause.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.html"
    },
    {
      "id": "section-31-3834.01",
      "number": "31-3834.01",
      "heading": "Full-year coverage for contraception.",
      "text": "(a) An individual health plan or group health plan, a health insurer offering health insurance coverage for prescription drugs, and health insurance coverage through Medicaid and the D.C. Healthcare Alliance program shall provide coverage for a supply of contraceptives intended to last over the course of a 12-month period, that shall be dispensed all at once or over the course of the 12 months at the patient's election, including for over-the-counter contraceptives and contraceptives obtained from a licensed pharmacist pursuant to § 3-1202.08(g-1); provided, that the D.C. Healthcare Alliance program shall not be required to provide coverage for a supply of contraceptives intended to last longer than the period of recertification for the D.C. Healthcare Alliance. The costs of any consultation by the pharmacist shall also be covered.\n\n(b) For the purposes of this section, the term:\n\n(1) \"Contraceptive\" means a drug or drug regimen approved by the U.S. Food and Drug Administration to prevent pregnancy.\n\n(2) \"Medicaid\" shall have the same meaning as provided in § 4-204.12(2).\n\n(c) Repealed.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5a",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.01.html"
    },
    {
      "id": "section-31-3834.02",
      "number": "31-3834.02",
      "heading": "Coverage of preventive health services.",
      "text": "(a) An individual health plan or group health plan and health insurance coverage through Medicaid or the D.C. Healthcare Alliance program shall provide coverage for, and shall not impose any cost-sharing requirements on, women for the following preventive health services and products:\n\n(A) Breast cancer screening;\n\n(A-i) Adjuvant breast cancer screening, including magnetic resonance imaging, ultrasound screening, or molecular breast imaging of the breast, if:\n\n(i) A mammogram demonstrates a Class C or Class D breast density classification; or\n\n(ii) A woman is believed to be at an increased risk for cancer due to family history or prior personal history of breast cancer, positive genetic testing, or other indications of an increased risk for cancer as determined by a woman's physician or advanced practice registered nurse;\n\n(B) Breast feeding support, services, and supplies;\n\n(C) Screening for cervical cancer, including HPV testing;\n\n(D) Screening for gestational diabetes;\n\n(E) Screening and counseling for HIV;\n\n(F) Screening and counseling for interpersonal and domestic violence;\n\n(G) Screening and counseling for sexually-transmitted diseases;\n\n(H) Screening and counseling for Hepatitis B and C;\n\n(I) Well-woman preventive visits, including visits to obtain necessary preventive care, preconception care, and prenatal care;\n\n(J) Folic acid supplementation;\n\n(K) Breast cancer chemoprevention counseling and preventive medications;\n\n(L) Risk assessment and genetic counseling and testing using the Breast Cancer Risk Assessment tool approved by the National Cancer Institute; and\n\n(M) Rh incompatibility screening;\n\n(2) Those evidence-based items or services that have in effect a rating of \"A\" or \"B\" in the recommendations of the United States Preventive Services Task Force as of September 19, 2017; and\n\n(3) Any additional health services or products identified by rules issued pursuant to subsection (c) of this section.\n\n(b) A health insurer and health insurance coverage through Medicaid or the D.C. Healthcare Alliance program offering health insurance coverage exclusively for prescription drugs shall provide coverage for, and shall not impose any cost-sharing requirements for women for contraceptive drugs, devices, products, and services, including those obtained over-the-counter and those prescribed and dispensed by a pharmacist pursuant to § 3-1202.08(g-1), and the following:\n\n(1) Those evidence-based prescription-drug items or related services that have in effect a rating of \"A\" or \"B\" in the recommendations of the United States Preventive Services Task Force as of September 19, 2017; and\n\n(2) Any additional contraceptive drugs, devices, products and services identified by rules issued pursuant to subsection (c) of this section.\n\n(1) Within 30 days after March 28, 2018, the Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules listing the items and services defined in subsections (a) and (b) of this section to be covered without imposing any cost-sharing requirements.\n\n(2) The Mayor shall amend the rules required by this subsection as necessary to:\n\n(A) Include additional preventive services or products for women or expansions of covered preventive services or products for women identified by the United States Preventive Services Task Force or the Health Resources and Services Administration of the United States Department of Health and Human Services after September 19, 2017; and\n\n(B) Remove items or services defined in subsections (a) and (b) of this section that a federal agency determines to pose a significant safety concern, consistent with the requirements of 45 C.F.R. § 147.130(b).\n\n(d) For the purposes of this section, the term \"breast density classification\" means the 4 levels of breast density identified in the Breast Imaging Reporting and Data System established by the American College of Radiology, which are:\n\n(A) Class A, indicating fatty breast tissue;\n\n(B) Class B, indicating scattered fibroglandular breast tissue;\n\n(C) Class C, indicating heterogeneously dense breast tissue with fibrous and glandular tissue that are evenly distributed throughout the breast; and\n\n(D) Class D, indicating extremely dense breast tissue.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5b",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.02.html"
    },
    {
      "id": "section-31-3834.03",
      "number": "31-3834.03",
      "heading": "Coverage of additional preventive health services.",
      "text": "(a) Health insurance coverage through Medicaid or the D.C. Healthcare Alliance program shall also provide coverage for and shall not impose any cost-sharing requirements for the following:\n\n(1) Voluntary sterilization procedures and services;\n\n(A) All contraceptive drugs, devices, products and services approved by the U.S. Food and Drug Administration (\"FDA\"), including emergency contraception; provided, that:\n\n(B) If there is a therapeutic equivalent of an FDA-approved contraceptive drug, device, product, or service, coverage shall also include either the original FDA-approved contraceptive drug, device, product, or service or at least one of its therapeutic equivalents, without imposing any cost-sharing requirements;\n\n(C) If the covered contraceptive drug, device, product, or service is deemed medically inadvisable by a provider, the health insurer shall defer to the determination and judgment of the attending provider and provide coverage for the alternative prescribed contraceptive drug, device, product, or service without imposing any cost-sharing requirements; and\n\n(D) Nothing in this section shall prohibit a health insurer from requiring the use of a generic prescription drug when providing coverage for preventive contraceptive drugs, devices, products, or services, so long as such health insurer:\n\n(i) Has a process for a member to seek medically necessary coverage of a covered brand name contraceptive drug, device, product, or service as determined by the member's prescribing provider; and\n\n(ii) Provides coverage for a brand name contraceptive drug, device, product, or service when there is no generic substitute available in the market;\n\n(3) Contraceptive services including consultation with a pharmacist, patient education, and counseling on contraceptive drugs, devices, products, or services; and\n\n(4) Follow-up services related to the drugs, devices, products, and services covered under this section, including management of side effects, counseling for continued adherence, and device insertion and removal.\n\n(b) Beginning on January 1, 2019, or the next date when carrier forms are approved, whichever is earlier, an individual health plan or group health plan shall also provide coverage for and shall not impose any cost-sharing requirements for all drugs, devices, products, and services listed in subsection (a) of this section; provided, that an individual health plan or group health plan subject to this subsection may require a co-payment or cost sharing for coverage of male contraceptive products for an enrollee covered by a high deductible health plan, as defined in section 1201(a) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, approved December 8, 2003 (117 Stat. 2066; 26 U.S.C. § 223(c)(2)).",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5c",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.03.html"
    },
    {
      "id": "section-31-3834.03a",
      "number": "31-3834.03a",
      "heading": "Coverage of additional reproductive services.",
      "text": "(1) An individual health plan or group health plan shall provide coverage for abortion and abortion-care services, including follow-up services, to an enrollee.\n\n(2) No individual health plan or group health plan shall impose any deductible, coinsurance, copayment, or other cost-sharing requirement, on an enrollee for the coverage required by this section; except, that an individual health plan or group health plan may require a deductible, co-payment, or cost sharing for an enrollee covered by a high deductible health plan, as defined in 26 U.S.C. § 223(c)(2), if required by federal law.\n\n(b) No individual health plan or group health plan covered under subsection (a) of this section shall impose any medically unnecessary restrictions or delays on the coverage required by this section.\n\n(c) Coverage for services under this section shall be provided without discrimination on the basis of age, ancestry, disability, domestic partner status, gender, gender expression, gender identity, genetic information, marital status, national origin, race, religion, sex, or sexual orientation.\n\n(d) This section shall not apply to health insurance coverage through Medicaid, the DC Healthcare Alliance program, or the Immigrant Children's program.\n\n(e) The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules to implement the provisions of this section.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5c-1",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.03a.html"
    },
    {
      "id": "section-31-3834.04",
      "number": "31-3834.04",
      "heading": "Religious exemption and accommodation.",
      "text": "(1) An employer organized and operating as a nonprofit entity and referred to in section 6033(a)(3)(A)(i) or (iii) of the Internal Revenue Code of 1986, approved October 22, 1986 (100 Stat. 2740; 26 U.S.C. § 6033(a)(3)(A)(i) or (iii)), may be exempt from any requirement to cover contraceptive or fertility enhancing drugs, devices, products, and services, abortion and abortion-care services, or voluntary sterilization procedures and services under §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, and 31-3834.07.\n\n(2) An employer claiming an exemption under this subsection shall provide its employees and prospective employees reasonable and timely notice of the exemption before enrollment with the group health plan, and the notice shall list the contraceptive drugs, devices, products, and services, abortion and abortion-care services, or voluntary sterilization procedures and services for which the employer does not provide coverage.\n\n(3) Nothing in this subsection shall be construed to allow for the exclusion of coverage for contraceptive drugs, devices, products, and service as prescribed by a provider, acting within his or her scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, or for contraceptive drugs, devices, products, and services that are necessary to preserve the life or health of an enrollee.\n\n(1) Nothing in this chapter shall be construed to require an employer to provide coverage for contraceptive drugs, devices, products, and services, abortion and abortion-care services, or voluntary sterilization procedures and services through its group health plan if the employer has provided to its group health insurance issuer a notice of request for accommodation, in a form and manner specified by the Mayor, and the insurer has certified that the employer meets the requirements of subsection (c) of this section.\n\n(2) Beginning on January 1, 2019, and on a quarterly basis thereafter, a group health insurance issuer shall notify the Department of Insurance, Securities, and Banking which employers have been granted an accommodation pursuant to subsection (c) of this section.\n\n(3) An employer that receives an accommodation pursuant to subsection (c) of this section shall provide, through its group health plan, coverage for contraceptive drugs, devices, products, and services as prescribed and dispensed by a provider, acting within her or her scope of practice, for reasons other than contraceptive purposes, such as decreasing the risk of ovarian cancer or eliminating symptoms of menopause, and for contraceptive drugs, devices, products, and services that are necessary to preserve the life or health of an enrollee.\n\n(c) A group health insurance issuer shall provide an employer with an accommodation to the requirements of §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, or 31-3834.07 upon receipt of a self-certification, in a form and manner specified by the Mayor, that the employer is:\n\n(1) A nonprofit entity that holds itself out as a religious organization and objects to covering some or all of the contraceptive or fertility enhancing drugs, devices, products, or services, abortion and abortion-care services, or voluntary sterilization procedures and services on account of its sincerely held religious beliefs; or\n\n(2) A closely-held for-profit entity; provided, that its highest governing body (such as its board of directors, board of trustees, or owners, if managed directly by its owners) has adopted a resolution or similar action establishing that it objects to covering some or all of the contraceptive or fertility enhancing drugs, devices, products, or services, abortion and abortion-care services, or voluntary sterilization procedures and services on account of the owners' sincerely held religious beliefs.\n\n(d) Upon receipt of a notice of request for accommodation that conforms to the requirements of subsection (c) of this section, a group health insurance issuer shall:\n\n(1) Exclude contraceptive or fertility enhancing drugs, devices, products, or services, abortion and abortion-care services, or voluntary sterilization procedures and services coverage from the group health insurance coverage provided in connection with the employer's group health plan; and\n\n(2) Provide separate payments for any contraceptive or fertility enhancing drugs, devices, products, or services required to be covered under §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, or 31-3834.07 without imposing any cost-sharing requirements or any other fee directly or indirectly on the employer, the group health plan, or plan participants or beneficiaries.\n\n(e) For the purposes of this section, the term \"closely-held for-profit entity\" means an entity that:\n\n(1) Is not a nonprofit entity;\n\n(2) Has no publicly traded ownership interests of any class of common equity securities required to be registered under section 12 of the Securities Exchange Act of 1934, approved June 6, 1934 (48 Stat. 892; 15 U.S.C. § 78l); and\n\n(3) Has more than 50% of the value of its ownership interest owned directly or indirectly by 5 or fewer individuals, or has an ownership structure that is substantially similar thereto, as of the date of the entity's self-certification pursuant to subsection (c) of this section.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5d",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.04.html"
    },
    {
      "id": "section-31-3834.05",
      "number": "31-3834.05",
      "heading": "Notice of rights to healthcare coverage.",
      "text": "(a) An insurer that is subject to §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, or 31-3834.07 shall make readily accessible to enrollees and potential enrollees information regarding:\n\n(1) Full and accurate information relevant to coverage and cost-sharing for contraceptive and fertility enhancing drugs, devices, products, and services, abortion and abortion-care services, and voluntary sterilization procedures and services by each health insurance plan, including an explanation of an insured's financial responsibility for payment of premiums, coinsurance, copayments, deductibles, and any other charges;\n\n(2) The coverage of other drugs, devices, products, and services described in §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, and 31-3834.07; and\n\n(3) The right to receive up to a 12-month supply of self-administered hormonal contraceptives prescribed and dispensed by a licensed pharmacist, pursuant to § 3-1202.08(g-1), without cost-sharing requirements.\n\n(1) The insurer shall provide the information described in subsection (a) of this section in a consumer-friendly format:\n\n(A) That can be viewed on the insurer's public website through a clearly identifiable link or tab without requiring an individual to create or access an account or enter a policy or contract number;\n\n(B) By email or letter within 14 days after a request by an enrollee; and\n\n(C) Within one year after March 28, 2018, or whenever written materials are reprinted, whichever is sooner, in written materials that explain benefits or coverage that are provided to enrollees and potential enrollees, including in an addendum summarizing benefits and coverage.\n\n(2) This subsection shall be construed consistently with section 2715 of the Public Health Services Act, as amended by the Patient Protection and Affordable Care Act, approved March 23, 2010 (124 Stat. 132; 42 U.S.C. § 300gg-15).\n\n(c) The Department of Insurance, Securities and Banking shall provide health insurers operating in the District of Columbia with an annual notice of their obligation to provide coverage for drugs, devices, products, and services, abortion and abortion-care services, and voluntary sterilization procedures and services described in §§ 31-3834.01, 31-3834.02, 31-3834.03, 31-3834.03a, 31-3834.06, and 31-3834.07.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5e",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.05.html"
    },
    {
      "id": "section-31-3834.06",
      "number": "31-3834.06",
      "heading": "Coverage of fertility treatments.",
      "text": "(1) Beginning January 1, 2025, a health insurer offering a large group health benefit plan shall provide coverage for the diagnosis and treatment of infertility, including in vitro fertilization and standard fertility preservation services, as provided in paragraph (2) of this subsection; provided that the treatment would be consistent with a physician's or surgeon's overall plan of care.\n\n(2) The health benefit plan shall cover:\n\n(A) At least 3 complete oocyte retrievals with unlimited embryo transfers from those oocyte retrievals or from any oocyte retrieval performed prior to January 1, 2025, in accordance with the guidelines of ASRM, using single embryo transfer when recommended and medically appropriate; and\n\n(B) The medical costs related to an embryo transfer to be made from an enrollee to a third-party; except, that the enrollee's coverage shall not extend to any medical costs of the surrogate or gestational carrier after the embryo transfer procedure.\n\n(1) Beginning January 1, 2025, a health insurer offering an individual health benefit plan or small group health plan shall provide coverage for the diagnosis and treatment of infertility, including in vitro fertilization and standard fertility preservation services, as provided in paragraph (2) of this subsection; provided that the treatment would be consistent with a physician's or surgeon's overall plan of care.\n\n(2) The health benefit plan shall cover:\n\n(A) At least 3 complete oocyte retrievals with unlimited embryo transfers from those oocyte retrievals or from any oocyte retrieval performed prior to January 1, 2025, in accordance with the guidelines of ASRM, using single embryo transfer when recommended and medically appropriate; and\n\n(B) The medical costs related to an embryo transfer to be made from an enrollee to a third-party; except, that the enrollee's coverage shall not extend to any medical costs of the surrogate or gestational carrier after the embryo transfer procedure.\n\n(1) Beginning January 1, 2024, the DC Healthcare Alliance program shall provide health insurance coverage for the diagnosis of infertility and any medically necessary ovulation enhancing drugs and medical services related to prescribing and monitoring the use of such drugs, which shall include at least 3 cycles of ovulation-enhancing medication treatment over an enrollee's lifetime.\n\n(2) By January 1, 2024, the Department of Health Care Finance shall submit an amendment to the Medicaid state plan to the Centers for Medicare & Medicaid Services to authorize coverage through Medicaid for the diagnosis of infertility and any medically necessary ovulation enhancing drugs and medical services related to prescribing and monitoring the use of such drugs, which shall include at least 3 cycles of ovulation-enhancing medication treatment over an enrollee's lifetime.\n\n(d) Within 180 days of September 6, 2023, the Department of Health Care Finance shall submit a report to the Council after consulting with the Centers for Medicare & Medicaid Services on whether in vitro fertilization and standard fertility preservation services are medically reasonable and necessary procedures under federal law, possible methods for covering in-vitro fertilization and standard fertility preservation services as a Medicaid covered benefit for both fee-for-service and managed care organizations, including any potentially applicable waiver authorities, and the amount of money that would need to be allocated to federal and local funds for such coverage.\n\n(e) Coverage for the treatment of infertility shall be provided without discrimination on the basis of age, ancestry, disability, domestic partner status, gender, gender expression, gender identity, genetic information, marital status, national origin, race, religion, sex, or sexual orientation.\n\n(f) A health insurer shall not impose:\n\n(1) Deductibles, copayments, coinsurance, benefit maximums, waiting periods or any other limitations on coverage for the diagnosis and treatment of infertility, including the prescription of fertility medications, different from those imposed upon benefits for services not related to infertility;\n\n(2) Pre-existing condition exclusions or pre-existing condition waiting periods on coverage for the diagnosis and treatment of infertility or use any prior diagnosis of or prior treatment for infertility as a basis for excluding, limiting, or otherwise restricting the availability of coverage for required benefits; or\n\n(3) Limitations on coverage based solely on arbitrary factors, including number of attempts, dollar amounts, or age, or provide different benefits to, or impose different requirements upon, a class protected under Unit A of Chapter 14 of Title 2 than that provided to, or required of, other patients.\n\n(g) Nothing in this section shall be construed to interfere with the clinical judgment of a physician or surgeon.\n\n(h) The health insurer shall notify all policyholders and all prospective group policyholders with whom they are negotiating of the availability of coverage provided under this section.\n\n(i) For the purposes of this section, the term:\n\n(1) \"ASRM\" means the American Society for Reproductive Medicine.\n\n(2) \"Infertility\" means a disease, condition, or status characterized by:\n\n(A) The failure to establish a pregnancy or to carry a pregnancy to live birth after regular, unprotected sexual intercourse in accordance with the guidelines of ASRM;\n\n(B) A person's inability to reproduce without medical intervention either as a single individual or with their partner; or\n\n(C) A licensed physician's findings based on a patient's medical, sexual, and reproductive history, age, physical findings, or diagnostic testing.\n\n(3) \"Treatment for infertility\" means procedures consistent with established medical practices in the treatment of infertility by licensed physicians and surgeons, including diagnosis, diagnostic tests, medication, surgery, or gamete intrafallopian transfer.\n\n(4) \"Standard fertility preservation services\" means procedures that are consistent with established medical practices or professional guidelines published by ASRM or the American Society of Clinical Oncology for a person who has a medical condition or is expected to undergo medication therapy, surgery, radiation, chemotherapy, or other medical treatment that is recognized by medical professionals to cause a risk of impairment to fertility.\n\n(j) The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules to implement the provisions of this section.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5f",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.06.html"
    },
    {
      "id": "section-31-3834.07",
      "number": "31-3834.07",
      "heading": "Coverage of voluntary sterilization procedures and services.",
      "text": "(a) Except as otherwise provided in subsection (b) of this section, an individual health plan or group health plan shall provide coverage for voluntary sterilization procedures and services and shall not impose any cost-sharing requirements or impose any medically unnecessary restrictions or delays.\n\n(b) An individual health plan or group health plan may require a deductible, co-payment, or cost sharing for coverage of voluntary sterilization procedures and services for an enrollee covered by a high deductible health plan, as defined in 26 U.S.C. § 223(c)(2), if required by federal law.\n\n(c) The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, shall issue rules to implement the provisions of this section.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 5g",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3834.07.html"
    },
    {
      "id": "section-31-3835",
      "number": "31-3835",
      "heading": "Prohibitions.",
      "text": "An individual or group health plan which is a health benefit plan, and a health insurer offering health care coverage, shall not:\n\n(1) Deny a patient eligibility, or continued eligibility, to enroll or renew coverage under terms of the health benefit plan, solely for the purpose of avoiding the requirements of this chapter; or\n\n(2) Penalize or otherwise reduce or limit the reimbursement of an attending provider, or provide incentives (monetary or otherwise) to an attending provider, to induce such provider to provide care to an individual participant or beneficiary in a manner inconsistent with this chapter.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 6, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3835.html"
    },
    {
      "id": "section-31-3836",
      "number": "31-3836",
      "heading": "Regulations.",
      "text": "The Commissioner shall promulgate regulations necessary to implement the provisions of this chapter within 180 days after April 3, 2001.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 7, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3836.html"
    },
    {
      "id": "section-31-3837",
      "number": "31-3837",
      "heading": "Applicability to group health plans.",
      "text": "The provisions of this chapter shall apply to group health benefit plans for years beginning on or after April 3, 2001.",
      "history": "Apr. 3, 2001, D.C. Law 13-254, § 8, 48 DCR 723",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3837.html"
    },
    {
      "id": "section-31-3841.01",
      "number": "31-3841.01",
      "heading": "Definitions.",
      "text": "(a) For the purposes of this chapter, the term:\n\n(1) \"Health insurer\" means a person that provides one or more health benefit plans or insurance in the District of Columbia, including an insurer, a hospital and medical services corporation, a fraternal benefit society, a health maintenance organization, a multiple employer welfare arrangement, or any other person providing a plan of health insurance subject to the authority of the Commissioner of the Department of Insurance, Securities, and Banking.\n\n(2) \"Open enrollment period\" means the yearly period during which a person can enroll in a health insurance plan.\n\n(3) \"Special enrollment period\" means any time a person has the option to enroll in or change their health insurance outside of the open enrollment period.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3841.01.html"
    },
    {
      "id": "section-31-3841.02",
      "number": "31-3841.02",
      "heading": "Pregnancy as a qualifying event.",
      "text": "(a) A health insurer shall allow for a special enrollment period for a pregnant individual for:\n\n(1) Sixty days when offering individual health insurance coverage from the date of confirmation of pregnancy, as certified by a licensed healthcare professional acting within the scope of the professional's practice; and\n\n(2) At least 30 days when offering group health insurance coverage from the date of confirmation of pregnancy, as certified by a licensed healthcare professional acting within the scope of the professional's practice.\n\n(b) Coverage shall be effective as of the first of the month in which the health care professional certifies the individual is pregnant, unless the individual elects to have coverage effective on the first day of the month following the date that the individual makes a plan selection.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3841.02.html"
    },
    {
      "id": "section-31-3861",
      "number": "31-3861",
      "heading": "Definitions.",
      "text": "(a) For the purposes of this chapter, the term:\n\n(1) “Health benefits plan” shall have the same meaning as provided in § 31-3131(4).\n\n(2) “Health insurer” shall have the same meaning as provided in § 31-3131(5).\n\n(2A) \"Postpartum\" means the time after delivery when maternal physiological changes related to pregnancy return to the nonpregnant state, which may last for as long as 12 months after delivery.\n\n(3) “Provider” shall have the same meaning as provided in § 31-3131(7).\n\n(4) “Telehealth” means the delivery of healthcare services through the use of interactive audio, video, or other electronic media used for the purpose of diagnosis, consultation, or treatment; provided, that services delivered through email messages or facsimile transmissions are not included.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 2, 60 DCR 11117",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3861.html"
    },
    {
      "id": "section-31-3862",
      "number": "31-3862",
      "heading": "Private reimbursement.",
      "text": "(a) A health insurer offering a health benefits plan in the District may not deny coverage for a healthcare service on the basis that the service is provided through telehealth if the same service would be covered when delivered in person.\n\n(b) A health insurer shall reimburse the provider for the diagnosis, consultation, or treatment of the insured when the service is delivered through telehealth.\n\n(c) A health insurer shall not be required to:\n\n(1) Reimburse a provider for healthcare service delivered through telehealth that is not a covered under the health benefits plan; and\n\n(2) Reimburse a provider who is not a covered provider under the health benefits plan.\n\n(d) A health insurer may require a deductible, copayment, or coinsurance amount for a healthcare service delivered through teleheath; provided, that the deductible, copayment, or coinsurance amount may not exceed the amount applicable to the same service when it is delivered in person.\n\n(e) A health insurer shall not impose any annual or lifetime dollar maximum on coverage for telehealth services other than an annual or lifetime dollar maximum that applies in the aggregate to all items and services under the health benefits plan.\n\n(f) Nothing in this chapter shall preclude the health insurer from undertaking utilization review to determine the appropriateness of telehealth as a means of delivering a healthcare service; provided, that the determinations shall be made in the same manner as those regarding the same service when it is delivered in person.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 3, 60 DCR 11117",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3862.html"
    },
    {
      "id": "section-31-3862.01",
      "number": "31-3862.01",
      "heading": "Postpartum maternal health services.",
      "text": "Not Funded.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 3a",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3862.01.html"
    },
    {
      "id": "section-31-3863",
      "number": "31-3863",
      "heading": "Medicaid reimbursement.",
      "text": "Medicaid shall cover and reimburse for healthcare services appropriately delivered through telehealth if the same services would be covered when delivered in person.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4, 60 DCR 11117",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3863.html"
    },
    {
      "id": "section-31-3864",
      "number": "31-3864",
      "heading": "Remote patient monitoring service providers; payment.",
      "text": "Repealed.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4a",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3864.html"
    },
    {
      "id": "section-31-3865",
      "number": "31-3865",
      "heading": "Right to synchronous interaction.",
      "text": "Repealed.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4b",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3865.html"
    },
    {
      "id": "section-31-3866",
      "number": "31-3866",
      "heading": "Facility fees.",
      "text": "Repealed.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4c",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3866.html"
    },
    {
      "id": "section-31-3867",
      "number": "31-3867",
      "heading": "Federal authorization.",
      "text": "Repealed.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4d",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3867.html"
    },
    {
      "id": "section-31-3868",
      "number": "31-3868",
      "heading": "Rules.",
      "text": "Repealed.",
      "history": "Oct. 17, 2013, D.C. Law 20-26, § 4e",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3868.html"
    },
    {
      "id": "section-31-3871",
      "number": "31-3871",
      "heading": "Medically necessary foods.",
      "text": "(a) A health benefits plan issued, renewed, extended, or modified in the District by a health insurer after December 31, 2022, shall provide coverage for the cost of medically necessary food ordered as necessary by a provider for the following diseases or conditions:\n\n(1) Inflammatory bowel disease, including Crohn's disease, ulcerative colitis, and indeterminate colitis;\n\n(2) Gastroesophageal reflux disease that is nonresponsive to standard medical therapies;\n\n(3) Immunoglobulin E- and non-Immunoglobulin E-mediated allergies to food proteins;\n\n(4) Food protein-induced enterocolitis syndrome;\n\n(5) Eosinophilic disorders, including eosinophilic esophagitis, eosinophilic gastroenteritis, eosinophilic colitis, and post-transplant eosinophilic disorders;\n\n(6) Impaired absorption of nutrients caused by disorders affecting the absorptive surface, functional length, and motility of the gastrointestinal tract, including short bowel syndrome and chronic intestinal pseudo-obstruction;\n\n(7) Malabsorption due to liver or pancreatic disease;\n\n(8) Inherited metabolic disorders; and\n\n(9) Any other diseases or conditions as determined by the Mayor through rulemaking.\n\n(b) The coverage provided under this section shall not be more restrictive than or separate from coverage provided for any other illness, condition, or disorder for purposes of determining deductibles, benefit year or lifetime durational limits, benefit year or lifetime dollar limits, lifetime episodes or treatment limits, copayment and coinsurance factors, and benefit year maximum for deductibles and copayments and coinsurance factors.\n\n(c) The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, may issue rules to implement the provisions of this chapter.\n\n(d) For the purposes of this section, the term:\n\n(1) \"Health benefits plan\" means any accident and health insurance policy or certificate, hospital and medical services corporation contract, health maintenance organization subscriber contract, plan provided by a multiple employer welfare arrangement, or plan provided by another benefit arrangement. The term \"health benefit plan\" does not include accident only, credit, or disability insurance; coverage of Medicare services or federal employee health plans, pursuant to contracts with the United States government; Medicare supplemental or long-term care insurance; dental only or vision only insurance; specified disease insurance; hospital confinement indemnity coverage; limited benefit health coverage; coverage issued as a supplement to liability insurance, insurance arising out of a workers' compensation or similar law; automobile medical payment insurance; medical expense and loss of income benefits; or insurance under which benefits are payable with or without regard to fault and that is statutorily required to be contained in any liability insurance policy or equivalent self-insurance.\n\n(2) \"Health insurer\" means a person that provides one or more health benefit plans or insurance in the District, including an insurer, a hospital and medical services corporation, a fraternal benefit society, a health maintenance organization, a multiple employer welfare arrangement, or any other person providing a plan of health insurance subject to the authority of the Department of Insurance, Securities, and Banking.\n\n(3) \"Medically necessary food\" means food, including a low-protein modified food product or an amino acid preparation product, a modified fat preparation product, or a nutritional formula that is specially formulated and processed for the partial or exclusive feeding of an individual by means of oral intake or enteral feeding by tube, and intended for dietary management of an individual who, because of therapeutic or chronic medical needs, has limited or impaired capacity to ingest, digest, absorb, or metabolize ordinary foodstuffs or certain nutrients or who has other specially medically determined nutrient requirements, the dietary management of which cannot be achieved by modification of the normal diet alone.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3871.html"
    },
    {
      "id": "section-31-3875.01",
      "number": "31-3875.01",
      "heading": "Definitions.",
      "text": "(a) For purposes of this chapter, the term:\n\n(1) \"Adverse determination\" means a decision by a utilization review entity that the health care services furnished or proposed to be furnished to an enrollee is denied, reduced, or terminated as being not medically necessary or experimental or investigational.\n\n(2) \"Approval\" means a determination by a utilization review entity that a covered health care service has been reviewed and, based on the information provided, satisfies the utilization review entity's requirements for medical necessity and medical appropriateness.\n\n(3) \"Emergency health care service\" means a health care service that is provided in an emergency facility after the sudden onset of a medical condition that manifests itself by symptoms of sufficient severity, including severe pain, that the absence of immediate medical attention could reasonably be expected by a prudent layperson, who possesses an average knowledge of health and medicine, to place the patient's health in serious jeopardy or to cause serious impairment to bodily function or serious dysfunction of any bodily organ or part.\n\n(4) \"Enrollee\" means an individual eligible to receive health care benefits by a health insurer pursuant to a health plan or other health insurance coverage.\n\n(5) Not Funded.\n\n(6) \"Medication assisted treatment\" means the use of medications to provide a comprehensive approach to the treatment of substance use disorders.\n\n(7) \"Prior authorization\" means the process by which a utilization review entity determines the medical necessity or medical appropriateness of covered health care services prior to the rendering of such services, including any notification that an enrollee or health care provider is required to provide to the health insurer or utilization review entity prior to the provision of a health care service.\n\n(8) \"Representative\" means the enrollee's legally authorized representative.\n\n(9) \"Urgent health care service\" means:\n\n(A) A health care service that, in the opinion of a physician with knowledge of the enrollee's medical condition, if not receiving an expedited approval:\n\n(i) Could seriously jeopardize the life or health of the enrollee or the ability of the enrollee to regain maximum function; or\n\n(ii) Could subject the enrollee to severe pain that cannot be adequately managed without the care or treatment that is the subject of the prior authorization review; or\n\n(B) Medication assisted treatment.\n\n(10) \"Utilization review entity\" means an individual or entity that performs prior authorization review for:\n\n(A) A health insurer as that term is defined in § 4-631;\n\n(B) A preferred provider organization or health maintenance organization as those terms are described in § 1-621.05(2) and (3);\n\n(C) Not Funded.\n\n(D) Not Funded.\n\n(E) Any other individual or entity that provides, offers to provide, or administers hospital, outpatient, medical, prescription drug, or other health benefits to a person treated by a health care provider in the District under a policy, plan, or contract that is regulated by the District.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.01.html"
    },
    {
      "id": "section-31-3875.02",
      "number": "31-3875.02",
      "heading": "Prior authorization requirements and restrictions.",
      "text": "(1) A utilization review entity may only require prior authorization for a covered health care service based on a determination of medical necessity for different care or that the proposed care is experimental or investigational in nature.\n\n(2) A utilization review entity may not require prior authorization:\n\n(A) Based solely on the cost of a covered health care service; provided, that:\n\n(i) Not Funded.\n\n(ii) Not Funded.\n\n(B) For the provision of medication assisted treatment; or\n\n(C) For pre-hospital transportation or for the provision of emergency health care services, including emergency health care services to screen and stabilize an enrollee.\n\n(b) A utilization review entity shall:\n\n(1) Post its current prior authorization requirements and restrictions, including formulary (\"prior authorization requirements\"), on its website, in a manner accessible to the general public without the need to create an account;\n\n(2) Email or provide a hard copy of the prior authorization requirements to an enrollee, representative, or health care provider upon request by telephone or in writing; and\n\n(3) Provide information on its prior authorization requirements, upon request, to an enrollee, representative, or health care provider over the telephone.\n\n(c) Prior authorization requirements shall:\n\n(1) Be described in detail and easily understandable language;\n\n(2) Include any written clinical criteria;\n\n(3) Include a comprehensive listing of all drugs that require prior authorization; and\n\n(4) Include the process for submitting, and standards for considering, including evidence-based guidelines, where possible, requests for:\n\n(A) Prior authorization approval;\n\n(B) Reauthorization of a prior grant of approval; and\n\n(C) An appeal of an adverse determination.\n\n(d) If a utilization review entity intends to amend or replace its prior authorization requirements, any changes to the requirements shall not be effective until the utilization review entity's website has been updated to reflect the new requirements.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.02.html"
    },
    {
      "id": "section-31-3875.03",
      "number": "31-3875.03",
      "heading": "Prior authorization in non-urgent, urgent, and emergency circumstances.",
      "text": "(a) If a utilization review entity requires prior authorization of a health care service, the utilization review entity shall, after receiving all required information to make its decision, make an approval or adverse determination and notify the enrollee, representative, and the enrollee's health care provider of its decision within:\n\n(1) For an urgent health care service, 24 hours;\n\n(2) Not Funded.\n\n(3) For all other health care services, 3 business days of receiving the request via electronic portal or 5 business days of receiving the request via mail, telephone, or facsimile.\n\n(b) A health care service described under subsection (a) of this section shall be deemed approved if the utilization review entity does not provide notice within the time frames provided by that subsection.\n\n(c) The notice required under subsection (a) of this section shall include:\n\n(1) The qualifications of the individual making the determination, including:\n\n(A) States in which the individual is licensed;\n\n(B) Status of their medical licenses; and\n\n(C) Their medical specialty; and\n\n(2) For an adverse determination, an explanation of:\n\n(A) The utilization review entity's reasons for making an adverse determination based on its prior authorization requirements;\n\n(B) The enrollee's right to appeal;\n\n(C) The process to file an appeal; and\n\n(D) All information necessary to support a successful appeal of the adverse determination.\n\n(1) If the utilization review entity determines that required information is missing, the utilization review entity shall promptly notify the enrollee, representative, and the enrollee's health care provider of its need for additional information.\n\n(2) Prior to issuing an adverse determination, the utilization review entity shall notify the enrollee's health care provider that the medical necessity of the health care service is being questioned and give the responsible physician an opportunity to provide additional information or clarification on the medical necessity of the health care service.\n\n(1) A utilization review entity shall provide an enrollee, representative, and the enrollee's health care provider a minimum of 24 hours (excluding weekends and legal public holidays) following an emergency hospital admission or the provision of an emergency health care service to notify the utilization review entity of the admission or provision of the emergency health care service.\n\n(2) If a health care provider certifies in writing to a utilization review entity within 72 hours of an enrollee's receipt of an emergency health care service that the enrollee's condition required the provision of such service, the service shall be presumed to have been medically necessary and may be rebutted only if the utilization review entity establishes through clear and convincing evidence that the emergency health care service was not medically necessary.\n\n(3) A utilization review entity may not consider whether the emergency health care service was provided by a nonparticipating provider when determining the medical necessity or appropriateness of the service and may not impose greater restrictions on the coverage of emergency health care services provided by nonparticipating providers than those that apply to the same services provided by participating providers.\n\n(f) For purposes of this section, the term \"required information\" includes the results of any face-to-face clinical evaluation or second opinion that may be required under the utilization review entity's prior authorization requirements.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.03.html"
    },
    {
      "id": "section-31-3875.04",
      "number": "31-3875.04",
      "heading": "Length of prior authorization.",
      "text": "(a) Except as otherwise provided in subsection (b) of this section, approval shall be valid for at least one year from the date the enrollee receives notice of the approval and shall remain valid regardless of any changes in dosage for a prescription drug prescribed by the health care provider; provided, that the utilization review entity may rescind the approval for dosages exceeding limitations set by federal or District laws or regulations.\n\n(1) Approval for a course of treatment, as that term is defined at 2 CFR 422.112(b)(8)(ii)(A), or for a health care service to treat a chronic condition, shall remain valid for as long as medically reasonable and necessary to avoid disruptions in care, in accordance with applicable coverage criteria, the enrollee's medical history, and the treating provider's recommendation.\n\n(2) Not Funded.\n\n(c) A utilization review entity may not revoke, limit, condition, or restrict approval if care is provided within 45 business days from the date the enrollee receives notice of the approval; provided, that approval may be revoked or otherwise restricted in cases of fraud.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.04.html"
    },
    {
      "id": "section-31-3875.05",
      "number": "31-3875.05",
      "heading": "Appeals.",
      "text": "(a) A utilization review entity shall provide an enrollee with at least 15 calendar days from the date the enrollee receives notice of an adverse determination to appeal the decision via the utilization review entity's website, facsimile, or mail; provided, that an appeal submitted by mail shall be considered timely if postmarked within 15 calendar days of the enrollee receiving notice.\n\n(b) In reviewing an appeal, the utilization review entity shall consider all known clinical aspects of the health care service under review, including a review of all pertinent medical records, other relevant records, and any medical literature provided by the enrollee, representative, or the enrollee's health care provider.\n\n(c) The enrollee, representative, and the enrollee's health care provider shall be notified within 24 hours of the utilization review entity making a decision on the appeal, which shall include the following information:\n\n(1) The qualifications of the physician reviewing the appeal including:\n\n(A) States in which the physician is licensed;\n\n(B) Status of their medical licenses;\n\n(C) Their medical specialty; and\n\n(D) Years of practice in that specialty; and\n\n(2) The grounds for the physician's decision under the utilization review entity's prior authorization requirements.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.05.html"
    },
    {
      "id": "section-31-3875.06",
      "number": "31-3875.06",
      "heading": "Review personnel qualifications.",
      "text": "(1) A utilization review entity shall ensure that an adverse determination is made by a physician who:\n\n(A) Possesses a current and valid non-restricted license to practice medicine in the District, Maryland, or Virginia; and\n\n(B) Is of the same or similar specialty as a physician who typically manages the medical condition or disease or provides the health care service involved in the request; provided, that a physician making an adverse determination for pediatric care shall have a pediatric specialty.\n\n(2) The reviewing physician shall:\n\n(A) Be under the clinical direction of one of the utilization review entity's medical directors licensed in the District who is responsible for providing health care services to enrollees in the District; and\n\n(B) Not receive any financial incentive based on the number of adverse determinations made; except, that the utilization review entity may establish medically appropriate performance standards.\n\n(1) A utilization entity shall ensure that all appeals are reviewed by a physician who:\n\n(A) Possesses a current and valid non-restricted license to practice medicine in the District, Maryland, or Virginia;\n\n(B) Is of the same or similar specialty as a physician who typically manages the medical condition or disease or provides the health care service involved in the request; provided, that the physician reviewing an appeal for pediatric care shall have a pediatric specialty and practiced that specialty for at least 5 years; and\n\n(C) Is knowledgeable of, and have experience providing, the health care service on appeal.\n\n(2) A physician reviewing an appeal shall not:\n\n(A) Receive any financial incentive based on the number of adverse determinations made or upheld on appeal; provided, that the utilization review entity may establish medically appropriate performance standards;\n\n(B) Have been directly involved in making the adverse determination; and\n\n(C) Be subordinate of the physician who made the adverse determination.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.06.html"
    },
    {
      "id": "section-31-3875.07",
      "number": "31-3875.07",
      "heading": "Continuity of care for enrollees.",
      "text": "(1) A utilization review entity shall honor an approval granted by a previous utilization review entity for at least the initial 60 days of an enrollee's coverage under the new health benefits plan; provided, that the utilization review entity may condition honoring the approval on receipt of information documenting the approval.\n\n(2) During the 60-day period described in subsection (a) of this section, a utilization review entity may perform its own prior authorization review; provided, that if the utilization review entity issues an adverse determination following review, the adverse determination shall not take effect before the end of the 60-day period described in subsection (a) of this section.\n\n(b) If a health insurer changes coverage of, or approval criteria for, a health care service for which an enrollee previously received approval, the change in coverage or approval criteria shall not apply to an enrollee who received approval prior to the effective date of the change for the duration of the approval.\n\n(c) A utilization review entity shall honor a prior grant of approval to an enrollee who changes health benefit plans offered by the same health insurer.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.07.html"
    },
    {
      "id": "section-31-3875.08",
      "number": "31-3875.08",
      "heading": "Failure to comply and penalties.",
      "text": "(a) Any failure by a utilization review entity to comply with the requirements specified in this chapter shall result in the health care service in question being deemed approved.\n\n(b) An action by a utilization review entity that establishes a pattern or practice of repeated violations of this chapter, as determined by the Commissioner of the Department of Insurance and Securities Regulation, shall constitute a violation of Chapter 22A of this title.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.08.html"
    },
    {
      "id": "section-31-3875.09",
      "number": "31-3875.09",
      "heading": "Data transparency.",
      "text": "(1) Beginning January 1, 2025, a utilization review entity shall make available on its website, or by phone upon request, to an enrollee, representative, and health care provider, the information required by paragraph (2) of this subsection regarding the enrollee's active prior authorization requests made to that utilization review entity in at least the preceding 5 years; provided that, this paragraph shall not apply to a prior authorization request made before January 17, 2024.\n\n(2) The following information shall be made available to an enrollee:\n\n(A) A copy of all information or materials submitted by the enrollee's health care provider in support of a request for approval or reauthorization, or an appeal from an adverse determination, which shall clearly show the date the information or materials were submitted, the health care service prescribed by the health care provider, and the reason, if any, provided by the health care provider in requesting the health care service; and\n\n(B) A copy of all notices of determination provided to the enrollee issued pursuant to § 31-3875.03.\n\n(b) Beginning January 1, 2025, a utilization review entity shall make publicly available on its website in a readily accessible format statistics regarding approvals, adverse determinations, and appeals, including information on the:\n\n(1) Specialties of physicians reviewing prior authorization requests or appeals;\n\n(2) Types of medication, tests, procedures, or treatment in which approval was being sought;\n\n(3) Medical indication offered in each request;\n\n(4) Reasons for an adverse determination;\n\n(5) Number of appeals taken;\n\n(6) Number of appeals approved or denied;\n\n(7) Time between submission of a request and the utilization review entity's determination; and\n\n(8) Time between submission of an appeal and the utilization review entity's determination.\n\n(c) For the purposes of this section, the term \"utilization review entity\" shall not include an individual or entity that performs prior authorization review for a health benefits plan provided through Medicaid or the DC HealthCare Alliance.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.09.html"
    },
    {
      "id": "section-31-3875.10",
      "number": "31-3875.10",
      "heading": "Rulemaking.",
      "text": "The Mayor, pursuant to subchapter I of Chapter 5 of Title 2, may issue rules to implement the provisions of this chapter.",
      "history": "",
      "source_url": "https://code.dccouncil.us/us/dc/council/code/sections/31-3875.10.html"
    }
  ]
}